Plain-English translation of NCT07790406 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying a newer robotic surgical technique called the da Vinci Single-Port system, which removes lung tumors through just one small cut under the rib cage instead of multiple cuts. Doctors believe this approach causes less pain and helps patients recover faster, while still effectively treating early-stage lung cancer just as well as traditional surgery.
While traditional lung cancer surgery works well, it requires multiple cuts between the ribs, which can be painful and slow recovery. This trial exists to confirm that the newer single-port robotic technique is just as safe and effective at treating cancer while being gentler on patients' bodies.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would either be enrolled before your surgery or after you've already had the single-port robotic procedure performed. Researchers will collect information about your surgery and recovery — including how much pain you have, how quickly you heal, and whether the cancer was completely removed. This is mainly a data collection study, so your involvement centers on allowing doctors to track your surgical outcomes and recovery over time.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
Italy
Enrollment target
~50 participants
Started
February 2026
Primary completion
March 2032
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Monica Casiraghi, MD PhD
European Institute of Oncology
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.